NO20065902L - 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler - Google Patents

3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler

Info

Publication number
NO20065902L
NO20065902L NO20065902A NO20065902A NO20065902L NO 20065902 L NO20065902 L NO 20065902L NO 20065902 A NO20065902 A NO 20065902A NO 20065902 A NO20065902 A NO 20065902A NO 20065902 L NO20065902 L NO 20065902L
Authority
NO
Norway
Prior art keywords
oxazolidin
triazol
ylmethyl
pyridin
phenyl
Prior art date
Application number
NO20065902A
Other languages
English (en)
Inventor
Michael Barry Gravestock
Fei Zhou
Folkert Beck
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411592A external-priority patent/GB0411592D0/en
Priority claimed from GB0500053A external-priority patent/GB0500053D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20065902L publication Critical patent/NO20065902L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Forbindelser med formel I, samt farmasøytisk akseptable salter og prodrugs derav, er beskrevet, hvor R1, R2, R3 og R4 er som definert heri. Også beskrevet er fremgangsmåter for fremstilling av forbindelser med formel I samt fremgangsmåter for anvendelse av forbindelser med formel I for behandling av bakterielle infeksjoner.
NO20065902A 2004-05-25 2006-12-19 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler NO20065902L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411592A GB0411592D0 (en) 2004-05-25 2004-05-25 Chemical compounds
GB0500053A GB0500053D0 (en) 2005-01-05 2005-01-05 Chemical compounds
PCT/GB2005/002055 WO2005116023A1 (en) 2004-05-25 2005-05-24 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents

Publications (1)

Publication Number Publication Date
NO20065902L true NO20065902L (no) 2007-02-20

Family

ID=34968777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065902A NO20065902L (no) 2004-05-25 2006-12-19 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler

Country Status (9)

Country Link
US (1) US20080021071A1 (no)
EP (1) EP1753755A1 (no)
JP (1) JP2008500318A (no)
AU (1) AU2005247670A1 (no)
BR (1) BRPI0511524A (no)
CA (1) CA2567929A1 (no)
IL (1) IL179347A0 (no)
NO (1) NO20065902L (no)
WO (1) WO2005116023A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2010042887A2 (en) 2008-10-10 2010-04-15 Trius Therapeutics Methods for preparing oxazolidinones and compositions containing them
KR101918678B1 (ko) 2009-02-03 2018-11-14 머크 샤프 앤드 돔 코포레이션 Ｒ)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
CN102260277B (zh) * 2010-05-24 2013-07-24 中国科学院上海药物研究所 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
WO2013169651A1 (en) * 2012-05-07 2013-11-14 The University Of North Carolina At Chapel Hill Direct anti-markovnikov addition of acids to alkenes
WO2014179648A2 (en) * 2013-05-02 2014-11-06 The University Of North Carolina At Chapel Hill Direct anti-markovnikov addition of acids to alkenes
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
EP3795563B1 (en) 2016-03-31 2024-07-17 Oncternal Therapeutics, Inc. Indoline analogs and uses thereof
WO2021258013A1 (en) 2020-06-18 2021-12-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
IL303195A (en) 2020-11-25 2023-07-01 Akagera Medicines Inc Lipid nanoparticles for delivery of nucleic acids and related methods of use
EP4531819A2 (en) 2022-05-25 2025-04-09 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
BR0111280A (pt) * 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
JP2005524661A (ja) * 2002-02-28 2005-08-18 アストラゼネカ アクチボラグ ３−シクリル−５−（窒素含有５員環）メチル−オキサゾリジノン誘導体と抗菌剤としてのその使用
MXPA05005522A (es) * 2002-11-28 2005-07-25 Astrazeneca Ab Oxazolidinonas como agentes antibacterianos.
JP5043428B2 (ja) * 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
EP1654259A1 (en) * 2003-07-02 2006-05-10 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
AR046782A1 (es) * 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.

Also Published As

Publication number Publication date
WO2005116023A1 (en) 2005-12-08
IL179347A0 (en) 2007-03-08
BRPI0511524A (pt) 2007-12-26
EP1753755A1 (en) 2007-02-21
CA2567929A1 (en) 2005-12-08
US20080021071A1 (en) 2008-01-24
AU2005247670A1 (en) 2005-12-08
WO2005116023A8 (en) 2007-01-11
JP2008500318A (ja) 2008-01-10

Similar Documents

Publication Publication Date Title
NO20054852L (no) GFAT inhibitorer
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
TW200502230A (en) Dual nk1/nk3 derivatives
NO20076066L (no) Oksadiazolderivater som DGAT-inhibitorer
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20044866L (no) Pyrazolo-pyrimidin-anilin-forbindelser anvendelige som kinase-inhibitorer
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
EP1163910A4 (en) PREVENTIVE / MEDICINE AGAINST INTERSTITIAL PNEUMONIA AND PULMONAL FIBROSIS
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
ATE420639T1 (de) Antimykotische mittel
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
NO20062629L (no) Oksazolderivater av tetrackliner
NO20065873L (no) 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application